Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duvakitug in T2-low/Non-T2 Severe Asthma
NCT04545385Phase 2Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2020
- Primary completion
- Jan 2022
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of duvakitug in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2020; status: terminated.
02
Drugs
duvakitug
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04545385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545385.